Xeris Biopharma (XERS) Institutional Ownership

$5.89 -0.11 (-1.83%)

Closing price 04:00 PM Eastern

Extended Trading

$5.95 +0.06 (+1.02%)

As of 07:32 PM Eastern

Compare

Current Institutional Ownership Percentage: 42.75%
Number of Institutional Buyers (last 12 months): 152
Total Institutional Inflows (last 12 months): $180.10M

Number of Institutional Sellers (last 12 months): 78
Total Institutional Outflows (last 12 months): $198.42M

Get XERS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XERS Institutional Buying and Selling by Quarter

Xeris Biopharma Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2026	Bank of America Corp DE	874,397	$5.07M	0.0%	+21.8%	0.506%
5/19/2026	Janus Henderson Group PLC	295,489	$1.71M	0.0%	+322.8%	0.171%
5/18/2026	California State Teachers Retirement System	180,339	$1.05M	0.0%	+19.3%	0.104%
5/18/2026	Royal Bank of Canada	43,610	$253K	0.0%	+12.9%	0.025%
5/16/2026	The Manufacturers Life Insurance Company	72,804	$422K	0.0%	+59.0%	0.042%
5/16/2026	Quantinno Capital Management LP	30,971	$180K	0.0%	+25.4%	0.018%
5/15/2026	Rice Hall James & Associates LLC	251,066	$1.46M	0.1%	N/A	0.145%
5/15/2026	Granahan Investment Management LLC	921,854	$5.35M	0.3%	-24.6%	0.534%
5/15/2026	Entropy Technologies LP	20,432	$119K	0.0%	N/A	0.012%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	464,084	$2.69M	0.0%	-13.7%	0.269%
Get the Latest News and Ratings for XERS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xeris Biopharma and its competitors with MarketBeat's FREE daily newsletter.
5/14/2026	Renaissance Technologies LLC	452,860	$2.63M	0.0%	-26.9%	0.262%
5/14/2026	Arrowstreet Capital Limited Partnership	133,760	$776K	0.0%	-37.7%	0.077%
5/14/2026	Knott David M Jr	1,060,000	$6.15M	3.6%	+9.3%	0.614%
5/14/2026	Sei Investments Co.	579,210	$3.36M	0.0%	+45.0%	0.336%
5/14/2026	State of Wyoming	10,420	$60K	0.0%	-75.5%	0.006%
5/13/2026	Cetera Investment Advisers	44,397	$258K	0.0%	+14.9%	0.026%
5/7/2026	AlphaCentric Advisors LLC	45,886	$266K	0.3%	+5.7%	0.027%
5/7/2026	KBC Group NV	4,573	$27K	0.0%	N/A	0.003%
5/7/2026	Swiss National Bank	328,300	$1.90M	0.0%	+3.1%	0.190%
5/5/2026	Bank of New York Mellon Corp	426,285	$2.47M	0.0%	-1.8%	0.247%
5/4/2026	Emerald Mutual Fund Advisers Trust	207,543	$1.20M	0.1%	N/A	0.120%
5/4/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	13,650	$79K	0.0%	-15.1%	0.008%
5/4/2026	Principal Financial Group Inc.	208,507	$1.21M	0.0%	+38.5%	0.121%
5/4/2026	Chicago Partners Investment Group LLC	13,493	$81K	0.0%	N/A	0.008%
4/30/2026	Hsbc Holdings PLC	31,175	$183K	0.0%	N/A	0.018%
4/29/2026	R Squared Ltd	13,802	$80K	0.0%	N/A	0.008%
4/27/2026	Y Intercept Hong Kong Ltd	161,793	$938K	0.0%	+78.5%	0.094%
4/25/2026	Strs Ohio	17,600	$102K	0.0%	-73.1%	0.010%
4/22/2026	Pictet Asset Management Holding SA	29,999	$174K	0.0%	+29.3%	0.017%
4/20/2026	Apella Capital LLC	235,897	$1.50M	0.0%	-4.1%	0.137%
4/16/2026	SG Americas Securities LLC	121,911	$707K	0.0%	+10.6%	0.071%
3/9/2026	Corient Private Wealth LLC	10,734	$84K	0.0%	N/A	0.006%
2/19/2026	Invesco Ltd.	112,130	$880K	0.0%	-80.8%	0.068%
2/19/2026	Corient Private Wealth LLC	10,734	$84K	0.0%	N/A	0.006%
2/18/2026	VARCOV Co.	31,005	$243K	0.1%	N/A	0.019%
2/18/2026	Voloridge Investment Management LLC	811,129	$6.37M	0.0%	-21.6%	0.489%
2/18/2026	Virtus Investment Advisers LLC	37,102	$291K	0.1%	+44.1%	0.022%
2/18/2026	Tudor Investment Corp ET AL	22,186	$174K	0.0%	-41.6%	0.013%
2/18/2026	Millennium Management LLC	859,051	$6.74M	0.0%	+63.7%	0.518%
2/18/2026	Man Group plc	47,775	$375K	0.0%	N/A	0.029%
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes
2/18/2026	IHT Wealth Management LLC	263,531	$2.07M	0.1%	+2.1%	0.159%
2/18/2026	Ishara Investments LP	800,000	$6.28M	7.3%	N/A	0.482%
2/18/2026	Engineers Gate Manager LP	89,404	$702K	0.0%	-18.7%	0.054%
2/18/2026	9823 Capital L.P.	24,917	$196K	0.1%	N/A	0.015%
2/17/2026	Schonfeld Strategic Advisors LLC	234,723	$1.84M	0.0%	-22.9%	0.141%
2/17/2026	AQR Capital Management LLC	957,579	$7.52M	0.0%	-2.6%	0.577%
2/17/2026	Jain Global LLC	11,114	$87K	0.0%	N/A	0.007%
2/17/2026	Trexquant Investment LP	213,581	$1.68M	0.0%	-6.9%	0.129%
2/17/2026	Jump Financial LLC	341,068	$2.68M	0.0%	-43.5%	0.206%
2/17/2026	Price T Rowe Associates Inc. MD	173,463	$1.36M	0.0%	+4.0%	0.105%
2/17/2026	Osaic Holdings Inc.	52,285	$410K	0.0%	+29.6%	0.032%
2/17/2026	Diadema Partners LP	170,568	$1.34M	0.2%	+128.2%	0.103%
2/17/2026	Russell Investments Group Ltd.	364,786	$2.86M	0.0%	+45.1%	0.220%
2/17/2026	Granahan Investment Management LLC	1,223,404	$9.60M	0.4%	+249.4%	0.737%
2/17/2026	Kemnay Advisory Services Inc.	8,480	$67K	0.0%	N/A	0.005%
2/17/2026	State of Wisconsin Investment Board	357,453	$2.81M	0.0%	+2.0%	0.215%
2/17/2026	Royal Bank of Canada	38,636	$304K	0.0%	+6.5%	0.023%
2/17/2026	Persistent Asset Partners Ltd	45,609	$358K	0.2%	+165.1%	0.027%
2/17/2026	Faithward Advisors LLC	106,730	$838K	0.1%	N/A	0.064%
2/16/2026	Squarepoint Ops LLC	482,832	$3.79M	0.0%	-28.9%	0.291%
2/16/2026	Truvestments Capital LLC	8,118	$64K	0.0%	+96.1%	0.005%
2/16/2026	Healthcare of Ontario Pension Plan Trust Fund	537,483	$4.22M	0.0%	+111.6%	0.324%
2/16/2026	Kennedy Capital Management LLC	1,213,969	$9.53M	0.2%	+0.2%	0.732%
2/16/2026	Barclays PLC	362,751	$2.85M	0.0%	+4.6%	0.219%
2/16/2026	Aigen Investment Management LP	12,262	$96K	0.0%	-35.9%	0.007%
2/13/2026	Kestra Advisory Services LLC	3,192	$25K	0.0%	N/A	0.002%
2/13/2026	The Manufacturers Life Insurance Company	45,801	$360K	0.0%	-8.7%	0.028%
2/13/2026	Quarry LP	80,000	$628K	0.1%	-3.0%	0.048%
2/13/2026	Essex Investment Management Co. LLC	734,532	$5.77M	0.9%	-2.1%	0.443%
2/13/2026	Rafferty Asset Management LLC	33,689	$264K	0.0%	+93.5%	0.020%
2/13/2026	Charles Schwab Investment Management Inc.	1,403,824	$11.02M	0.0%	-3.0%	0.846%
2/13/2026	State Street Corp	4,116,924	$32.32M	0.0%	+10.1%	2.481%
2/13/2026	Ieq Capital LLC	86,520	$679K	0.0%	-19.9%	0.052%
2/13/2026	Dynamic Technology Lab Private Ltd	17,200	$135K	0.0%	N/A	0.010%
2/13/2026	Caitong International Asset Management Co. Ltd	7,501	$59K	0.2%	+9,276.3%	0.005%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	651,445	$5.11M	0.0%	+255.1%	0.393%
2/13/2026	Wells Fargo & Company MN	170,796	$1.34M	0.0%	+75.7%	0.103%
2/13/2026	Castleark Management LLC	445,950	$3.50M	0.1%	N/A	0.269%
2/12/2026	HRT Financial LP	332,326	$2.61M	0.0%	+358.1%	0.200%
2/12/2026	MetLife Investment Management LLC	81,594	$641K	0.0%	-6.6%	0.049%
2/12/2026	Cibc World Markets Corp	10,158	$80K	0.0%	N/A	0.006%
2/12/2026	Renaissance Technologies LLC	619,660	$4.86M	0.0%	-61.8%	0.373%
2/12/2026	EntryPoint Capital LLC	68,083	$534K	0.2%	+28.4%	0.041%
2/12/2026	Integrated Quantitative Investments LLC	66,170	$519K	0.1%	N/A	0.040%
2/12/2026	Federated Hermes Inc.	854,888	$6.71M	0.0%	+21.4%	0.515%
2/12/2026	AlphaCentric Advisors LLC	43,392	$341K	0.3%	N/A	0.026%
2/12/2026	Informed Momentum Co LLC	80,154	$629K	0.1%	-86.7%	0.048%
2/12/2026	Rosalind Advisors Inc.	2,111,700	$16.58M	6.1%	+17.6%	1.273%
2/12/2026	Campbell & CO Investment Adviser LLC	47,454	$373K	0.0%	-54.2%	0.029%
2/12/2026	Knott David M Jr	970,000	$7.61M	3.5%	-4.4%	0.585%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad) We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it. 👉 Unlock the ticker now and get it completely free.
2/12/2026	Swiss National Bank	318,400	$2.50M	0.0%	+2.6%	0.192%
2/12/2026	Nuveen LLC	2,806,806	$22.03M	0.0%	-0.7%	1.692%
2/11/2026	Janney Montgomery Scott LLC	24,450	$192K	0.0%	-6.7%	0.015%
2/11/2026	Deutsche Bank AG	940,592	$7.38M	0.0%	-40.0%	0.567%
2/11/2026	Fox Run Management L.L.C.	26,174	$205K	0.0%	N/A	0.016%
2/11/2026	Cerity Partners LLC	29,578	$232K	0.0%	-4.7%	0.018%
2/11/2026	LPL Financial LLC	84,861	$666K	0.0%	+154.8%	0.051%
2/11/2026	Franklin Resources Inc.	121,428	$953K	0.0%	+11.3%	0.073%
2/11/2026	CenterBook Partners LP	1,391,590	$10.92M	0.5%	+99.3%	0.839%
2/11/2026	JPMorgan Chase & Co.	895,059	$7.03M	0.0%	-1.1%	0.539%

XERS Institutional Ownership - Frequently Asked Questions

During the previous two years, 230 institutional investors and hedge funds held shares of Xeris Biopharma. The most heavily invested institutionals were Vanguard Group Inc. ($87.82M), Geode Capital Management LLC ($33.57M), State Street Corp ($32.32M), Qube Research & Technologies Ltd ($26.66M), Nuveen LLC ($22.03M), Rosalind Advisors Inc. ($16.58M), and Parkman Healthcare Partners LLC ($14.58M).Learn more on Xeris Biopharma's institutional investors.

42.75% of Xeris Biopharma's stock is owned by institutional investors. Learn more on XERS's institutional investor holdings.

Of the 206 institutional investors that purchased Xeris Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nuveen LLC ($2.23M), CenterBook Partners LP ($1.82M), Walleye Capital LLC ($1.81M), Vanguard Group Inc. ($1.71M), Connor Clark & Lunn Investment Management Ltd. ($1.70M), Parkman Healthcare Partners LLC ($1.68M), and UBS Group AG ($1.55M).

Institutional investors have bought a total of 25,858,004 shares in the last 24 months. This purchase volume represents approximately $180.10M in transactions.

Of the 78 institutional investors that sold Xeris Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. ($10.40M), Millennium Management LLC ($2.41M), Invesco Ltd. ($1.41M), JPMorgan Chase & Co. ($1.35M), UBS Group AG ($1.18M), Renaissance Technologies LLC ($1.17M), and CenterBook Partners LP ($896.03K).

Institutional investors have sold a total of 26,320,478 shares in the last 24 months. This volume of shares sold represents approximately $198.42M in transactions.

Related Companies

This page (NASDAQ:XERS) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xeris Biopharma (XERS) Institutional Ownership

XERS Institutional Buying and Selling by Quarter

Xeris Biopharma Major Shareholders & Ownership History

XERS Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xeris Biopharma (XERS) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Xeris Biopharma (NASDAQ:XERS)

XERS Institutional Buying and Selling by Quarter

Xeris Biopharma Major Shareholders & Ownership History

XERS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of XERS shares?

What percentage of Xeris Biopharma's stock is owned by institutional investors?

Which institutional investors have been buying Xeris Biopharma's stock?

How much institutional buying is happening at Xeris Biopharma?

Which of Xeris Biopharma's major shareholders have been selling company stock?

How much institutional selling is happening at Xeris Biopharma?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools